Dr. Vath joined Zafgen in 2006 and brings over 20 years of experience in the biotechnology and pharmaceutical industries to his role as head of discovery and development. Prior to joining the company, Dr. Vath worked with established companies and new ventures to assess, develop and execute product development plans. As senior vice president of product development at Phylogix Inc., Dr. Vath created and implemented the corporate operational and R&D plan for the lead product in oncology-supportive care. Prior to Phylogix, he served as senior vice president of research at Praecis Pharmaceuticals where he led the R&D organization through multiple IND filings and a product approval. Dr. Vath also held roles as director of protein technologies at Millennium Pharmaceuticals and a lab head in development at Genetics Institute. Dr. Vath is a contributing author on numerous peer-reviewed journal publications and book chapters. Dr. Vath earned his Ph.D. in chemistry from the Massachusetts Institute of Technology and a B.S. in chemistry from Northeastern University.